title: In vitro study on the effects of some selected agonists and antagonists of alpha(1)-adrenergic receptors on the contractility of the aneurysmally-changed aortic smooth muscle in humans.
abstract: The study included 18 sections of the aneurysmally-changed abdominal aortas, obtained from patients of the Provincial Specialist Hospital in Wroclaw and 18 sections of normal abdominal aortas obtained from swine. The collected samples were placed horizontally in the incubation chamber. Changes in their transverse section area were registered. They were stretched to a tension of 5 mN. Krebs-Henseleit buffer was used as the incubatory environment. Incubation of the sections was performed at a temperature of 37°C, in the gaseous mixture of oxygen and carbon dioxide used in the following proportion: 95% of O(2) and 5% of CO(2). Contractions of the aorta were registered with isotonic transducers (Letica Scientific Instruments). In the studies, we examined the influence of α(1)-adrenergic receptors (and their subtypes α(1A), α(1B), α(1D)) on the contractility of the aortic muscle in humans and swine by their stimulation or inhibition with some selected agonists or antagonists. This time, it was shown that the stimulation of α(1)-adrenergic receptors leads to contractions of the human and swine aortic muscle; the observed increase in the muscle tone may follow from the stimulation of all subtypes of alpha-1 receptor (α(1A), α(1B), α(1D)). All three subtypes of 1-adrenergic receptor are engaged in vasoconstriction, especially of α(1A) and α(1D) subtypes; the α(1B) subtype is less significant for aortic contractility. The contractile response of the aneurysmally-changed abdominal aorta in humans to agonists of α-adrenergic receptors was significantly less intense than that of the normal porcine aorta. It can be concluded that aneurysms influence the contractile response of the aorta.
authors.affiliation: General and Vascular Surgery Ward, Regional Specialist Hospital in Wroclaw, Research and Development Centre, Wroclaw, Poland.
authors.forename: J
authors.initials: J
authors.lastname: Gnus
authors.forename: A
authors.initials: A
authors.lastname: Czerski
authors.forename: S
authors.initials: S
authors.lastname: Ferenc
authors.forename: W
authors.initials: W
authors.lastname: Zawadzki
authors.forename: W
authors.initials: W
authors.lastname: Witkiewicz
authors.forename: W
authors.initials: W
authors.lastname: Hauzer
authors.forename: A
authors.initials: A
authors.lastname: Rusiecka
authors.forename: J
authors.initials: J
authors.lastname: Bujok
mesh_terms: D058646:Adrenergic alpha-1 Receptor Agonists / Q000494:pharmacology*; D058668:Adrenergic alpha-1 Receptor Antagonists / Q000494:pharmacology*; D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000503:physiopathology; D017544:Aortic Aneurysm, Abdominal / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology; D009131:Muscle, Smooth, Vascular / Q000187:drug effects* / Q000503:physiopathology; D018340:Receptors, Adrenergic, alpha-1 / Q000378:metabolism*; D013552:Swine; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology
chemical_list: D058646:Adrenergic alpha-1 Receptor Agonists; D058668:Adrenergic alpha-1 Receptor Antagonists; D018340:Receptors, Adrenergic, alpha-1